Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Lepeltier

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Drug Delivery and Translational Research|April 8, 2024
Nanomedicines via the pulmonary route: a promising strategy to reach the target?Mélina Guérin, Elise Lepeltier
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 5, 2021
Microbiota and nanoparticles: Description and interactionsAbdallah Ladaycia, Catherine Passirani, Elise Lepeltier
Advanced Drug Delivery Reviews|January 4, 2014
Nanoprecipitation and the "Ouzo effect": Application to drug delivery devicesElise Lepeltier, Claudie Bourgaux, Patrick Couvreur
Cancers|June 2, 2021
Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant TumorsPierre Idlas, Elise Lepeltier, Gérard Jaouen, et al.
Pharmacological Research|February 23, 2017
Nanomedicine as a potent strategy in melanoma tumor microenvironmentVincent Pautu, Daniela Leonetti, Elise Lepeltier, et al.
Bioconjugate Chemistry|September 17, 2016
Design of Polyamine-Grafted Starches for Nucleotide Analogue Delivery: In Vitro Evaluation of the Anticancer ActivityErdem Kanber, Hiroe Yamada, Brigitta Loretz, et al.
Advanced Drug Delivery Reviews|January 3, 2021
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicinesAbdallah Ladaycia, Brigitta Loretz, Catherine Passirani, et al.
Nanoscale Advances|September 22, 2022
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug deliveryMilad Baroud, Elise Lepeltier, Sylvain Thepot, et al.
Cancers|September 28, 2023
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?Michèle Salmain, Marie Gaschard, Milad Baroud, et al.
Colloids and Surfaces. B, Biointerfaces|February 9, 2024
Diversely substituted poly(N-vinyl amide) derivatives towards non-toxic, stealth and pH-responsive lipid nanocapsulesFrançois Toussaint, Elise Lepeltier, Florence Franconi, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Drug Delivery and Translational Research|April 8, 2024
Nanomedicines via the pulmonary route: a promising strategy to reach the target?Mélina Guérin, Elise Lepeltier
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V|November 5, 2021
Microbiota and nanoparticles: Description and interactionsAbdallah Ladaycia, Catherine Passirani, Elise Lepeltier
Advanced Drug Delivery Reviews|January 4, 2014
Nanoprecipitation and the "Ouzo effect": Application to drug delivery devicesElise Lepeltier, Claudie Bourgaux, Patrick Couvreur
Cancers|June 2, 2021
Ferrocifen Loaded Lipid Nanocapsules: A Promising Anticancer Medication against Multidrug Resistant TumorsPierre Idlas, Elise Lepeltier, Gérard Jaouen, et al.
Pharmacological Research|February 23, 2017
Nanomedicine as a potent strategy in melanoma tumor microenvironmentVincent Pautu, Daniela Leonetti, Elise Lepeltier, et al.
Bioconjugate Chemistry|September 17, 2016
Design of Polyamine-Grafted Starches for Nucleotide Analogue Delivery: In Vitro Evaluation of the Anticancer ActivityErdem Kanber, Hiroe Yamada, Brigitta Loretz, et al.
Advanced Drug Delivery Reviews|January 3, 2021
Microbiota and cancer: In vitro and in vivo models to evaluate nanomedicinesAbdallah Ladaycia, Brigitta Loretz, Catherine Passirani, et al.
Nanoscale Advances|September 22, 2022
The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug deliveryMilad Baroud, Elise Lepeltier, Sylvain Thepot, et al.
Cancers|September 28, 2023
Thioredoxin Reductase and Organometallic Complexes: A Pivotal System to Tackle Multidrug Resistant Tumors?Michèle Salmain, Marie Gaschard, Milad Baroud, et al.
Colloids and Surfaces. B, Biointerfaces|February 9, 2024
Diversely substituted poly(N-vinyl amide) derivatives towards non-toxic, stealth and pH-responsive lipid nanocapsulesFrançois Toussaint, Elise Lepeltier, Florence Franconi, et al.
Pageof 4